Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
American Journal of Hypertension
|
March 31, 2005
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension
Muzahir H Tayebjee, Ioannis Karalis, Sunil K Nadar, et al.
Angiology
|
May 24, 2011
Angiogenin and hemoxygenase in pregnancy: influence of hypertension
Velore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
Angiology
|
May 11, 2011
Soluble Fas and Fas ligand in pregnancy: influence of hypertension
Velore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
European Journal of Clinical Investigation
|
April 18, 2025
Prediction of major outcomes in patients with malignant hypertension using machine learning: A report from the West Birmingham malignant hypertension registry
Antonios A Argyris, Hironori Ishiguchi, Yang Chen, et al.
Journal of Hypertension
|
August 8, 2025
Long-term risk of adverse events in patients discharged alive after hospitalization for hypertensive crisis
Tommaso Bucci, Steven H M Lam, Antonios A Argyris, et al.
American Journal of Hypertension
|
January 9, 2003
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management
Dirk C Felmeden, Charles G C Spencer, Funmi M Belgore, et al.
The American Journal of Cardiology
|
August 14, 2003
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT])
Dirk C Felmeden, Charles G C Spencer, Natali A Y Chung, et al.
Lancet (London, England)
|
September 13, 2005
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
Björn Dahlöf, Peter S Sever, Neil R Poulter, et al.
Lancet (London, England)
|
September 13, 2005
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)
Neil R Poulter, Hans Wedel, Björn Dahlöf, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
American Journal of Hypertension
|
March 31, 2005
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension
Muzahir H Tayebjee, Ioannis Karalis, Sunil K Nadar, et al.
Angiology
|
May 24, 2011
Angiogenin and hemoxygenase in pregnancy: influence of hypertension
Velore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
Angiology
|
May 11, 2011
Soluble Fas and Fas ligand in pregnancy: influence of hypertension
Velore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
European Journal of Clinical Investigation
|
April 18, 2025
Prediction of major outcomes in patients with malignant hypertension using machine learning: A report from the West Birmingham malignant hypertension registry
Antonios A Argyris, Hironori Ishiguchi, Yang Chen, et al.
Journal of Hypertension
|
August 8, 2025
Long-term risk of adverse events in patients discharged alive after hospitalization for hypertensive crisis
Tommaso Bucci, Steven H M Lam, Antonios A Argyris, et al.
American Journal of Hypertension
|
January 9, 2003
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management
Dirk C Felmeden, Charles G C Spencer, Funmi M Belgore, et al.
The American Journal of Cardiology
|
August 14, 2003
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT])
Dirk C Felmeden, Charles G C Spencer, Natali A Y Chung, et al.
Lancet (London, England)
|
September 13, 2005
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
Björn Dahlöf, Peter S Sever, Neil R Poulter, et al.
Lancet (London, England)
|
September 13, 2005
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)
Neil R Poulter, Hans Wedel, Björn Dahlöf, et al.
Page
of 5